HK1219101A1 - 作為 激酶抑制劑的 三唑並 吡啶的衍生物 - Google Patents

作為 激酶抑制劑的 三唑並 吡啶的衍生物

Info

Publication number
HK1219101A1
HK1219101A1 HK16107169.2A HK16107169A HK1219101A1 HK 1219101 A1 HK1219101 A1 HK 1219101A1 HK 16107169 A HK16107169 A HK 16107169A HK 1219101 A1 HK1219101 A1 HK 1219101A1
Authority
HK
Hong Kong
Prior art keywords
p38map
triazolo
pyridine
derivatives
kinase inhibitors
Prior art date
Application number
HK16107169.2A
Other languages
English (en)
Inventor
‧阿爾卡拉斯
‧潘查爾
‧詹寧斯
‧克裡蒂蘭德
‧赫爾利
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of HK1219101A1 publication Critical patent/HK1219101A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
HK16107169.2A 2013-06-06 2016-06-21 作為 激酶抑制劑的 三唑並 吡啶的衍生物 HK1219101A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2013/061706 WO2014194956A1 (en) 2013-06-06 2013-06-06 Derivatives of [1, 2, 4] triazolo [4, 3 - a] pyridine as p38 - map kinase inhibitors

Publications (1)

Publication Number Publication Date
HK1219101A1 true HK1219101A1 (zh) 2017-03-24

Family

ID=48628635

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16107169.2A HK1219101A1 (zh) 2013-06-06 2016-06-21 作為 激酶抑制劑的 三唑並 吡啶的衍生物

Country Status (9)

Country Link
US (1) US9573949B2 (zh)
EP (1) EP3004087B1 (zh)
KR (1) KR20160016973A (zh)
CN (1) CN105308044A (zh)
BR (1) BR112015029504A2 (zh)
CA (1) CA2914457A1 (zh)
HK (1) HK1219101A1 (zh)
RU (1) RU2637944C2 (zh)
WO (1) WO2014194956A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105968110B (zh) 2011-12-09 2018-04-27 奇斯药制品公司 激酶抑制剂
AR107165A1 (es) 2015-12-23 2018-03-28 Chiesi Farm Spa Inhibidores de quinasa
WO2017108738A1 (en) * 2015-12-23 2017-06-29 Chiesi Farmaceutici S.P.A. 1-(3-tert-butyl-2h-pyrazol-5-yl or 5-tert-butyl-isoxaol-3-yl)-3-(4-([1,2,4]triazolo[4,3-a]pyridin-6-yloxy)-1,2,3,4-tetrahydro-naphthalenyl) urea derivatives and their use as p38 mapk inhibitors
EP3474835B1 (en) * 2016-06-23 2023-07-05 University of Maryland, Baltimore Non-catalytic substrate-selective p38 -specific mapk inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
US10364245B2 (en) 2017-06-07 2019-07-30 Chiesi Farmaceutici S.P.A. Kinase inhibitors
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
CN108424372B (zh) * 2018-05-11 2021-08-10 浙江华贝药业有限责任公司 2，2，2-三氟-n-[(s)-4-羰基四氢萘-1-基]-乙酰胺的纯化工艺
CN115650824B (zh) * 2022-10-31 2024-01-23 合肥工业大学 手性二醇及其制备方法、制得的催化剂及制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73492C2 (en) * 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
EP1392661A1 (en) * 2001-05-16 2004-03-03 Boehringer Ingelheim Pharmaceuticals Inc. Diarylurea derivatives useful as anti-inflammatory agents
AP2326A (en) * 2004-08-12 2011-11-24 Pfizer Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors.
EP1984363A1 (en) * 2006-02-09 2008-10-29 Pfizer Limited Triazolopyridine compounds
BRPI1005327A2 (pt) * 2009-02-17 2019-09-24 Chiesi Farm Spa derivados de triazolopiridina como inibidores de p38 map quinase
GB201009731D0 (en) * 2010-06-10 2010-07-21 Pulmagen Therapeutics Inflamma Kinase inhibitors
CN105968110B (zh) 2011-12-09 2018-04-27 奇斯药制品公司 激酶抑制剂
BR112015029970A2 (pt) * 2013-06-06 2017-07-25 Chiesi Farm Spa inibidores de cinase

Also Published As

Publication number Publication date
EP3004087B1 (en) 2017-08-09
BR112015029504A2 (pt) 2017-07-25
CN105308044A (zh) 2016-02-03
WO2014194956A1 (en) 2014-12-11
RU2637944C2 (ru) 2017-12-08
KR20160016973A (ko) 2016-02-15
US20160108040A1 (en) 2016-04-21
EP3004087A1 (en) 2016-04-13
CA2914457A1 (en) 2014-12-11
RU2015151823A (ru) 2017-06-13
US9573949B2 (en) 2017-02-21

Similar Documents

Publication Publication Date Title
IL263404B (en) History of ring-fused bicyclic pyridyls as fgfr4 inhibitors
HK1219101A1 (zh) 作為 激酶抑制劑的 三唑並 吡啶的衍生物
SG11201600062RA (en) Pyrimidine derivatives as kinase inhibitors
EP2981535B8 (en) Urea derivatives useful as kinase inhibitors
ZA201507874B (en) 2-aminopyrido[4,3-d]pyrimidin-5-one derivatives and their use as wee-1 inhibitors
IL245660A0 (en) History of aminopyridines as tam family kinase inhibitors
PH12016501232A1 (en) Pyrazolo[1,5-a]pyridine derivatives and methods of their use
EP3016953A4 (en) Purinone compounds as kinase inhibitors
AP2015008783A0 (en) 6-(5-hydroxy-1h-pyrazol-1-yl) nicotinamida derivatives and their use as phd inhibitors
HK1222396A1 (zh) 作為選擇性蛋白質激酶抑制劑之苯並咪唑衍生物
HK1219057A1 (zh) 大環的鹽可誘導的激酶抑制劑
HK1219481A1 (zh) 大環的 激酶抑制劑
EP2970278A4 (en) Pyrrolo [2,3] PYRIDINE KINASE INHIBITORS CDK9-
HK1258911A1 (zh) 可用作c-fms激酶抑制劑的取代的吡啶衍生物
EP2968995A4 (en) INHIBITORS OF LRRK2 KINASE ACTIVITY
IL274874A (en) Dialkyl(oxido)-4 LAMDA-converted sulfenylidine nicotinamide derivatives as kinase inhibitors
HK1213885A1 (zh) 作為 抑制劑的咪唑並-三嗪衍生物
EP2968324A4 (en) SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS
HK1224282A1 (zh) -三唑並 吡啶的製備方法
GB201309603D0 (en) Novel compounds and their use as kinase inhibitors
GB201305741D0 (en) Novel compounds and their use as kinase inhibitors